Sabby Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Sabby Management’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-104,059	Closed	-$51.1K	–	31
2026 Q1	$51.1K	Sell	104,059 -71,099	-41%	-$130K	0.11%	25
2025 Q4	$539K	Buy	175,158 +47,534	+37%	+$237K	0.78%	11
2025 Q3	$833K	Buy	127,624 +1,895	+2%	+$13.9K	0.96%	11
2025 Q2	$1.13M	Buy	+125,729	New	+$1.04M	2.04%	7

Sabby Management's LYRA Position: Q2 2026 in Review

Sabby Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2026, closing a stake of 104,059 shares — an estimated $51.1K sold.

Sabby Management first reported a position in LYRA in Q2 2025 and held it in 4 quarters. The position peaked at $1.13M in Q2 2025. 0 funds tracked by Wall St. Rank hold LYRA as of Q2 2026.

Sabby Management reported no remaining LYRA THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Sabby Management sold 104,059 LYRA THERAPEUTICS INC shares in Q2 2026, an estimated $51.1K.
Sabby Management first reported a position in LYRA THERAPEUTICS INC in Q2 2025 and held it in 4 quarters.
Sabby Management's LYRA THERAPEUTICS INC position peaked at $1.13M in Q2 2025.
0 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2026.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.